- Home
- CMMB vs GTIM Comparison
CMMB vs GTIM Comparison
Compare CMMB & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- GTIM
- Stock Information
- Founded
- CMMB 2004
- GTIM 1987
- Country
- CMMB Israel
- GTIM United States
- Employees
- CMMB N/A
- GTIM N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- GTIM Restaurants
- Sector
- CMMB Health Care
- GTIM Consumer Discretionary
- Exchange
- CMMB Nasdaq
- GTIM Nasdaq
- Market Cap
- CMMB 23.0M
- GTIM 17.0M
- IPO Year
- CMMB N/A
- GTIM 1990
- Fundamental
- Price
- CMMB $1.32
- GTIM $1.61
- Analyst Decision
- CMMB Strong Buy
- GTIM
- Analyst Count
- CMMB 2
- GTIM 0
- Target Price
- CMMB $8.50
- GTIM N/A
- AVG Volume (30 Days)
- CMMB 109.4K
- GTIM 22.0K
- Earning Date
- CMMB 05-15-2025
- GTIM 05-08-2025
- Dividend Yield
- CMMB N/A
- GTIM N/A
- EPS Growth
- CMMB N/A
- GTIM 65.30
- EPS
- CMMB N/A
- GTIM 0.09
- Revenue
- CMMB N/A
- GTIM $144,322,000.00
- Revenue This Year
- CMMB N/A
- GTIM N/A
- Revenue Next Year
- CMMB N/A
- GTIM N/A
- P/E Ratio
- CMMB N/A
- GTIM $17.03
- Revenue Growth
- CMMB N/A
- GTIM 4.14
- 52 Week Low
- CMMB $0.78
- GTIM $1.51
- 52 Week High
- CMMB $2.55
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- CMMB 50.69
- GTIM 38.43
- Support Level
- CMMB $1.31
- GTIM $1.51
- Resistance Level
- CMMB $1.44
- GTIM $1.64
- Average True Range (ATR)
- CMMB 0.08
- GTIM 0.08
- MACD
- CMMB 0.00
- GTIM 0.01
- Stochastic Oscillator
- CMMB 54.55
- GTIM 25.64
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.